Resource Center

Explore our comprehensive library of clinical publications, abstracts, news, events, newsletters, marketing materials and press releases.
Discover how Pulsenmore is shaping the future of healthcare delivery

Filter By:

Search
resources-top-bg
Discover Israel's thriving innovation ecosystem and the latest technologies on the horizon in this special edition as is takes a deep dive into Israel's remarkable 75-year history of innovation, highlighting

 Apr. 7, 2022, 08:00 AM RAMAT GAN, Israel, April 7, 2022 /PRNewswire/ — Home ultrasound developer Pulsenmore Ltd. (TASE: PULS) today announced the appointment of Hagar Spits as General Manager North America, as the company establishes U.S. operations

Discover Israel's thriving innovation ecosystem and the latest technologies on the horizon in this special edition as is takes a deep dive into Israel's remarkable 75-year history of innovation, highlighting

Pulsenmore has announced partnership with GE Healthcare, including an agreement to invest up to $50 million in Pulsenmore and distribution of its’ products in key markets. This investment is aimed

“In an office near Tel Aviv, a doctor checks the lungs of a Ukrainian refugee who is 2,000 kilometers away. It’s part of a new “virtual hospital” that has Israeli
"This is the first time I know of that a humanitarian mission is adding extraordinary value to the first responders there,” says Dr. Galia Barkai, director general of Sheba Beyond….
resources-bottom-bg

the news pulse

We invite you to keep up to date with the latest updates by registering to our quarterly newsletter

news-pulse-doctor
news-pulse-lady1
news-pulse-couple
news-pulse-lady2
about-collaborations-bottom-bg

FAQ

Frequently asked question

The Pulsenmore solution utilizes your smartphone’s processing and video streaming capabilities, communication protocols, display, and power resources. For this reason, not all smartphones meet the compatibility requirements. To insure your smartphone is compatible with the Pulsenmore Home Ultrasound check the Specification webpage.

Our commitment to patient safety and reliable scans guides the device’s design and functionality. The Pulsenmore device, connecting to a patient’s personal smartphone, optimally utilizes smartphone capabilities, minimizing material and resource consumption for enhanced environmental sustainability.

1. The Pulsenmore self-scan device is designed for use within a specific timeframe and usage limit. Extending its lifetime may compromise reading integrity due to material limitations.

2. Responsibility for device maintenance and home storage after the initial period cannot be assumed, impacting transducer quality and ultrasound scan reliability.

3. The device design and validated cleaning protocol do not allow transfer between patients, to avoid cross contamination and infection.

No, the product is subject to use in single pregnancies only.

The home ultrasound device is designed to provide continuity during pregnancy care and is intended to give you peace of mind.

Every scan requires medical interpretation, and it’s important to wait until the files are fully uploaded. You are not expected to understand or interpret the ultrasound scans; just follow the app’s instructions to scan, and receive a response from skilled ultrasound professionals .

You can view the scan in real-time while following the scanning instructions in the app. After the scan, the images are sent to the doctor and cannot be reviewed again.

In the App-Guided mode, the size of the zip file is about 20MB.The Clinician-Guided recorded scan is usually smaller, depending on the amount and length of clips.

Data is available for review for 30 days. During this time, the HCP can download and save the scans onto the patient file. More information is available in our Terms of Use.

No, the Clinician-Dashboard interface is an online web application that utilizes an active directory access technology (permission management tool).

The Pulsenmore Scan Key Code is generated by the HCP or admin within the clinician dashboard interface.It has unique identifiers based on the patient de-identified ID, selected mode (Clinician-Guided or App-Guided), and prescription details (frequency and time of use).The key is automatically transformed into a QR code and shared with the patient via email or SMS.

The device is designed for a single patient use, to prevent cross contamination.

Pulsenmore utilizes service logs and technical information to improve services and enhance user experience.Pseudonymized clinical data (also referred as de-identified data in the US) is used for clinical education,training, research and development purposes only.